Search
for
Sort by
Research 601–630 of 1000+
- Culprits of Medication-Induced Telogen Effluvium, Part 2
- Evaluación de la seguridad de minoxidil oral a dosis bajas en el tratamiento de la alopecia
- Minoxidil: effectiveness and prospects for use in the treatment of androgenetic alopecia
- Skin manifestations in adults with gender dysphoria on hormone treatment in the outpatient clinic of Hospital de San José, Bogotá—Colombia
- Becker’s Nevus in a Male: A Case Report
- What Do We Know About Hair Growth Induced by Wounding and Its Therapeutic Applications?
- Cholesterol homeostasis in hair follicle keratinocytes is disrupted by impaired ABCA5 activity
- Low-dose Oral Minoxidil in the Treatment of Alopecia: Evidence and Experience-based Consensus Statement of Indian Experts
- Oral Minoxidil 5 mg versus minoxidil 5% topical solution for the treatment of male androgenetic alopecia: a double-blind randomized clinical trial.
- 1379 Cyclosporin A suppresses TGF-β2 expression via calcineurin/NFAT pathway in human dermal papilla cells
- Low-Dose Oral Minoxidil for Alopecia: A Comprehensive Review
- Effects of Hormones and Endocrine Disorders on Hair Growth
- Lady with Long Eyelashes…!
- Diseases of the Hair
- Minoxidil in androgenic alopecia: New formulations with Improved delivery
- Bridging Personal and Population in Excitability Diseases: Will Studies of Rare Diseases Bring Generalizable Mechanisms From Monogenic Channelopathies?
- Alopecia androgenética: O uso do minoxidil e seus efeitos adversos
- Minoxidil oral en alopecia androgénica: estudio retrospectivo acerca de su seguridad en práctica clínica real
- Disorders of Hair
- Hair Disorders
- Minoxidil 1 mg orally versus minoxidil 5% solution topically for the treatment of female pattern hair loss: a randomized clinical trial
- Minoxidil
- Minoxidil and its use in hair disorders: a review
- Hair Disorders
- Uso de minoxidil no tratamento de alopecia de padrão feminino: revisão sistemática
- A rare hair loss in children: Monilethrix
- Dermatological Manifestations of Pegylated Interferon alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients
- 695 Using MALDI-MSI analysis to study distribution of FOL-005, a potent, novel inhibitor of human hair growth, after subcutaneous injection in mice
- Pathologies of the skin and its appendages in endocrine diseases
- Lasers in Onychomycosis